On September 26, 2024, the Board of Directors of Sanofi appointed Finexsi as independent expert, in accordance with AMF recommendations, in connection with the acquisition by Sanofi of 2,3% of its shares from L’Oréal, as part of Sanofi’s share buyback program announced on January 30, 2025.

Following its due diligence, Finexsi issued on February 1, 2025 a fairness opinion for the Board of Directors of Sanofi.

This assignment was led by Olivier Péronnet and Olivier Courau, assisted by Adeline Burnand.

Press Release: Sanofi announces buy back of shares from L’Oréal